Lantern Pharma Inc Sustainability Reports
Lantern Pharma Inc. is a clinical-stage oncology biotechnology company that uses artificial intelligence and genomics to innovate and accelerate the development of precision cancer therapeutics. The company leverages its proprietary RADR® platform to identify biomarker signatures that can predict patient response to its drug candidates.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00GM6LK26
2 reports from 2020 to 2022
Company Profile
Lantern Pharma Inc. is a clinical-stage oncology biotechnology company that uses artificial intelligence and genomics to innovate and accelerate the development of precision cancer therapeutics. The company leverages its proprietary RADR® platform to identify biomarker signatures that can predict patient response to its drug candidates.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
